Heparin injection recalled as Baxter investigates
Baxter issues voluntary recall of heparin
Reported adverse events associated with Baxter's heparin sodium injection 1000 units/ml have prompted the company to recall certain lots of the product while it investigates the cause. The affected lots include both 10-ml and 30-ml vials. The 10-ml vials affected are from lots 107054 and 117085. The 30-ml vials affected include lots 047056, 097081, 107024, 107064, 107066, 107074, and 107111. A complete list of reported adverse events can be found at
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
